Kevin Thornal, Division President, Diagnostic Solutions, explores the future of diagnostics

Hologic's Kevin Thornal was featured this month on Medical Device + Diagnostic Industry (MDDI) magazine's  “Let’s Talk MedTech” podcast. Topics covered include lessons learned from Hologic’s COVID-19 response, addressing current and future challenges in women’s health and infectious disease, including advancements in digital cytology, and the company's recent move into the rapidly growing molecular oncology space.

In 2020 and early 2021, Hologic contributed millions of molecular COVID tests to global supplies and launched the first ever digital cytology product, the Genius™ Digital Diagnostics System. The company also acquired Biotheranostics, with differentiated product offerings including Breast Cancer Index,™ which predicts which early-stage hormone receptor positive (HR+) breast cancer patients are likely to benefit from extended endocrine therapy and which can safely discontinue, saving medical costs and exposure to challenging side effects.  

go to podcast